SS

Sasiprabha Sethuraman

Active Director Director DIN 02714207
DIN 02714207 First appointment Sep 2009 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Sep 2009
Shareholding value •••• Premium profile

About Sasiprabha Sethuraman

Data last updated:

Sasiprabha Sethuraman has 17 years in corporate governance. Holds Director role. Currently with 2 companies, including Spinco Life Sciences (India) Private Limited and Special Instruments Consortium (India) Private Limited. Formerly with 2 companies, such as Neolife Hospital Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.48 Cr; the largest is Special Instruments Consortium (India) Private Limited at ₹1.46 Cr (FY 2025).

DIN 02714207
Primary Designation Director
First Appointment 05 Sep 2009
Oldest Company Age 23 yrs
Largest company Special Instruments Consortium (India) Private Limited · ₹1.46 Cr (FY 2025)
Combined revenue ₹1.48 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Sep 20092009₹1.46 Cr (FY 2025)Active
Director05 Sep 20092009₹1.7 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neolife Hospital Private Limited U85110TN2010PTC076362
Director29 Jun 20102010₹4.72 Cr (FY 2024)Active
Director01 Mar 20192002–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spinco Life Sciences (India) Private Limited
Special Instruments Consortium (India) Private Limited
Jaguar Instrument Technologies Private Limited
Neolife Hospital Private Limited
Premium access

Shareholding and investment profile for Sasiprabha Sethuraman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sasiprabha Sethuraman

Sasiprabha Sethuraman has 17 years in corporate governance. Holds Director role. Currently with 2 companies, including Spinco Life Sciences (India) Private Limited and Special Instruments Consortium (India) Private Limited. Formerly with 2 companies, such as Neolife Hospital Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.48 Cr; the largest is Special Instruments Consortium (India) Private Limited at ₹1.46 Cr (FY 2025).

Sasiprabha Sethuraman is associated with 2 companies as Director, including Special Instruments Consortium (India) Private Limited (₹1.46 Cr), Spinco Life Sciences (India) Private Limited (₹1.7 Lakh).

Sasiprabha Sethuraman has expertise in General Business, Technology.

Sasiprabha Sethuraman has 17 years in corporate governance.

By reported revenue, the largest current company of Sasiprabha Sethuraman is Special Instruments Consortium (India) Private Limited, with revenue of ₹1.46 Cr (FY 2025).

The 2 current companies of Sasiprabha Sethuraman that report revenue have a combined latest revenue of ₹1.48 Cr.

Sasiprabha Sethuraman currently holds positions at 2 companies: Special Instruments Consortium (India) Private Limited (₹1.46 Cr), Spinco Life Sciences (India) Private Limited (₹1.7 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available